Home

Sanjivani Paranteral Ltd PE Ratio

Image

Sanjivani Paranteral Ltd

NSE: SANJIVPARANT

PE

41.6

Last updated on: Apr 18, 2025

Key Highlights

  • The P/E Ratio of Sanjivani Paranteral Ltd is 41.6 as of 18 Apr 15:30 PM .
  • The P/E Ratio of Sanjivani Paranteral Ltd changed from 6.6 on March 2021 to 28.4 on March 2024 . This represents a CAGR of 44.03% over 4 years.
  • The Latest Trading Price of Sanjivani Paranteral Ltd is ₹ 251.05 as of 17 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.9. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Sanjivani Paranteral Ltd

No data available

Company Fundamentals for Sanjivani Paranteral Ltd

Image

Sanjivani Paranteral Ltd

NSE: SANJIVPARANT

Share Price

₹ 251.05

0.75 (0.30%)

stock direction

Last updated on: Apr 17, 2025

Market Price of Sanjivani Paranteral Ltd

1M

1Y

3Y

5Y

Monitoring Sanjivani Paranteral Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Apr 2025251.05
16 Apr 2025250.3
15 Apr 2025250.05
11 Apr 2025234.05
09 Apr 2025223.1
08 Apr 2025236.95
07 Apr 2025231.3
04 Apr 2025246.55
03 Apr 2025255.85
02 Apr 2025244.5

SWOT Analysis Of Sanjivani Paranteral Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Sanjivani Paranteral Ltd

Asset Value vs Market Value of Sanjivani Paranteral Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Sanjivani Paranteral Ltd298.29
Sun Pharmaceutical Industries Ltd420136
Divis Laboratories Ltd149680
Cipla Ltd122390
Torrent Pharmaceuticals Ltd110154
Mankind Pharma Ltd106555

PE Ratio of Sanjivani Paranteral Ltd Explained

298.29

Market cap

7

Earnings

41.6X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sanjivani Paranteral Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Sanjivani Paranteral Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Sanjivani Paranteral Ltd

No data available

* All values are in %

About Sanjivani Paranteral Ltd

  • Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades.
  • The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a public limited company in Oct.'94, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry.
  • The Company has been involved in the manufacturing of pharmaceutical medicines.
  • The Company's products includes oral solids, small volume parenteral and sterile powder formulations. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative.

Sanjivani Paranteral Ltd News Hub

Sanjivani Paranteral AGM scheduled

Sanjivani Paranteral announced that the 30th Annual General Meeting (AGM) of the company will be hel

Read more

12 Aug 24

Sanjivani Paranteral standalone net profit rises 10.32% in the June 2024 quarter

Net profit of Sanjivani Paranteral rose 10.32% to Rs 1.71 crore in the quarter ended June 2024 as ag

Read more

06 Aug 24

Sanjivani Paranteral announces board meeting date

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 9 September 202

Read more

05 Sept 24

Sanjivani Paranteral announces board meeting date

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 28 October 2024

Read more

22 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Sanjivani Paranteral Ltd

What is the current PE Ratio of Sanjivani Paranteral Ltd?

The Current PE Ratio of Sanjivani Paranteral Ltd is 41.63 as on 18 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 18 Apr 2025.

What was the PE Ratio of Sanjivani Paranteral Ltd last year?

The PE Ratio of Sanjivani Paranteral Ltd was 9.19 last year, now the PE ratio is 41.63, showing a year-on-year growth of 353.0%.

What does the PE Ratio of Sanjivani Paranteral Ltd indicate about its stock?

The PE Ratio of Sanjivani Paranteral Ltd is 41.63. This ratio indicates that investors are willing to pay 41.63 times the earnings per share for each share of Sanjivani Paranteral Ltd.

What is the PE Ratio Growth of Sanjivani Paranteral Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Sanjivani Paranteral Ltd grew by 353.0% whereas, the EPS ratio grew by -17.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions